Hospital Costs Soared for COVID Patients During Pandemic
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Jan. 3, 2024 -- The average cost of hospital care for COVID-19 patients skyrocketed during the pandemic, outstripping what might be expected under inflation, a new study shows.
Average hospital costs for COVID patients increased five times faster than the rate of medical inflation through the first two years of the pandemic, researchers have found.
This is at least partly due to the pricey medical technologies that had to be employed to fight the dangerous new infection, the researchers said.
The average cost of COVID hospitalization increased from about $10,000 during the first weeks of the pandemic to more than $13,000 by March 2022, researchers reported Jan. 3 in the journal JAMA Network Open.
Patients with health risk factors like obesity or hemophilia tended to run up higher medical bills, as well as those who required more intensive medical treatments, researchers said.
For example, patients had much higher costs if they required ECMO (extracorporeal membrane oxygenation), an assisted breathing treatment used later in the pandemic, researchers said.
“Defining the cost of treating hospitalized people with COVID-19 is important to fully understand the financial impact of the pandemic and improving public health readiness for future challenges,” said lead researcher Kandice Kapinos, a senior economist at RAND.
During the first two years of the pandemic, 6.2 million Americans were hospitalized for COVID infection, researchers said in background notes.
The peak demand for hospital services occurred during the Omicron wave, from November 2021 to February 2022, when COVID patients accounted for more than one-fifth of hospital admissions and took up nearly one-third of ICU beds, researchers said.
To evaluate the cost of treating those patients, researchers analyzed data covering 97% of the nation’s academic medical centers, more than 800 hospitals in total.
More than 80% of the hospitalized patients were admitted through the ER, researchers found. About 27% spent time in the ICU, 13% required mechanical ventilation, and 13% died.
The adjusted cost of caring for hospitalized COVID patients increased by 26% during the pandemic’s first two years, researchers found. By comparison, annual medical inflation ran between 2% and 5%.
Patients who needed ECMO or mechanical ventilation cost the most to treat, but were not necessarily the same patients who died, researchers said.
“The way doctors treated patients evolved as we learned about COVID-19,” Kapinos said in a RAND news release. “Then once the vaccines became available, the makeup of patients entering hospitals began to change.”
Given these findings, the direct cost of caring for all 6.2 million hospitalized COVID patients in those two years could have been as much as $70 billion, researchers said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-04 02:15
Read more
- NIH Clinical Trial Will Test Precision Medicine Treatments for Myeloid Cancers
- RSV Vaccination Prevents Associated Hospitalization, Emergency Encounters
- E. Coli Outbreak Linked to McDonald's Quarter Pounders Widens to 75 Cases in 13 States; 22 Hospitalized
- Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE
- COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions